Epicardial fat and the risk of atrial tachy-arrhythmia recurrence post pulmonary vein isolation: a computed tomography study.


Journal

The international journal of cardiovascular imaging
ISSN: 1875-8312
Titre abrégé: Int J Cardiovasc Imaging
Pays: United States
ID NLM: 100969716

Informations de publication

Date de publication:
Sep 2021
Historique:
received: 23 02 2021
accepted: 11 04 2021
pubmed: 29 4 2021
medline: 16 10 2021
entrez: 28 4 2021
Statut: ppublish

Résumé

Epicardial and Pericardia fat have been hypothesized to exert local and systemic pathogenic effects on nearby cardiac structures. The present study aimed to evaluate the impact of epicardial and pericardial fat volumes on the outcome of patients that underwent a first pulmonary vein isolation (PVI) with cryoablation. We included 130 consecutive patients with atrial fibrillation (AF) that underwent contrast enhanced ECG-gated cardiac computed tomography (CCT) before a PVI. The control group included 50 patients in normal sinus rhythm that underwent ECG-gated CT to rule out coronary artery disease. Epicardial and pericardial fat volumes were quantified with CCT. Patients with AF compared to patients with normal sinus rhythm (control group) had significantly larger epicardial (140.3 ± 58.1 vs. 55.9 ± 17.7 ml; respectively, P < 0.001) and pericardial (77.0 ± 35.5 ml vs. 27.2 ± 9.5 ml; respectively, P < 0.001) fat volumes. Among patients that underwent PVIs, those with AF recurrence had a greater epicardial (175.0 ± 54.4 ml vs. 130.7 ± SD 54.2 ml; respectively, P < 0.001) and pericardial (93.7 ± SD 42.8 vs. 72.5 ± SD 31.9 ml; respectively, P < 0.001) fat volumes, compared to patients with no AF recurrence. Multivariate analyses revealed that epicardial fat was an independent predictor of recurrence post-ablation (HR = 1.08, 95% CI 1.02-1.16 per 10-ml increase in volume; P = 0.009). Pericardial fat was associated with 7% increase in risk of recurrent AF (HR = 1.07, 95% CI 0.98-1.18; P = 0.117). Epicardial fat, assessed with contrast enhanced CCT, is an independent predictor of AF recurrence after PVI ablation.

Identifiants

pubmed: 33909226
doi: 10.1007/s10554-021-02244-w
pii: 10.1007/s10554-021-02244-w
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

2785-2790

Informations de copyright

© 2021. The Author(s), under exclusive licence to Springer Nature B.V.

Références

Flegal KM, Carroll MD, Ogden CL, Johnson CL (2002) Prevalence and trends in obesity among U.S. adults, 1999–2000. JAMA 288:1723–1727
doi: 10.1001/jama.288.14.1723
Hruby A, Hu FB (2015) The epidemiology of obesity: a big picture. PharmacoEconomics 33:673–689
doi: 10.1007/s40273-014-0243-x
Wang TJ, Parise H, Levy D, D’Agostino RB Sr, Wolf PA, Vasan RS et al (2004) Obesity and the risk of new-onset atrial fibrillation. JAMA 292:2471–2477
doi: 10.1001/jama.292.20.2471
Schnabel RB, Yin X, Gona P, Larson MG, Beiser AS, McManus DD et al (2015) 50-year trends in atrial fibrillation prevalence, incidence, risk factors, and mortality in the Framingham heart study: a cohort study. Lancet 386:154–162
doi: 10.1016/S0140-6736(14)61774-8
Wong CX, Sullivan T, Sun MT, Mahajan R, Pathak RK, Middeldorp ME et al (2015) Obesity and the risk of incident, post-operative, and post-ablation atrial fibrillation: a meta-analysis of 626,603 individuals in 51 studies. JACC Clin Electrophysiol 1:139–152
doi: 10.1016/j.jacep.2015.04.004
Al Chekakie M, Obadah Christine CW, Raymond Metoyer, Ibrahim A, Shapira AR, Cytron J et al (2010) Pericardial fat is independently associated with human atrial fibrillation. J Am Coll Cardiol 56(10):784–788
doi: 10.1016/j.jacc.2010.03.071
Munger TM, Dong Y-X, Masaki M, Oh JK, Mankad SV, Borlaug BA et al (2012) Electrophysiological and hemodynamic characteristics associated with obesity in patients with atrial fibrillation. J Am Coll Cardiol 60(9):851–860
doi: 10.1016/j.jacc.2012.03.042
Thanassoulis G, Massaro JM, O’Donnell CH, Hoffmann U, Levy D, Ellinor PT et al (2010) Pericardial fat is associated with prevalent atrial fibrillation: the Framingham heart study. Circ Arrhythm Electrophysiol 3(4):345–350
doi: 10.1161/CIRCEP.109.912055
Calkins H, Hindricks G, Cappato R, Hoon Kim Y, Saad EB, Aguinaga L et al (2017) 2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation. Heart Rhythm 14:e275–e444
doi: 10.1016/j.hrthm.2017.05.012
Wong CX, Abed HS, Molaee P, Nelson AJ, Brooks AG, Sharma G et al (2011) Pericardial fat is associated with atrial fibrillation severity and ablation outcome. J Am Coll Cardiol 57:1745–1751
doi: 10.1016/j.jacc.2010.11.045
January CT, Wann LS, Alpert JS, Calkins H, Cleveland JC, Cigarroa JE et al (2014) 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American heart association task force on practice guidelines and the heart rhythm society. Circulation 130:e199–e267
pubmed: 24682347 pmcid: 4676081
Wazni OM, Dandamudi G, Sood N, Hoyt R, Tyler J, Durrani S, on behalf of the STOP-AF First Trial Investigators et al (2021) Cryoballoon Ablation as Initial Therapy for Atrial Fibrillation. N Engl J Med 384:316–324
doi: 10.1056/NEJMoa2029554
Mahabadi AA, Lehmann N, Kalsch H, Bauer M, Dykun I, Kara K et al (2014) Association of epicardial adipose tissue and left atrial size on non-contrast CT with atrial fibrillation: the Heinz Nixdorf Recall Study. Eur Heart J Cardiovasc Imaging 15:863–869
doi: 10.1093/ehjci/jeu006
Mahajan R, Lau DH, Brooks AG, Shipp NJ, Manavis J, Wood JP et al (2015) Electrophysiological, electroanatomical, and structural remodeling of the atria as consequences of sustained obesity. J Am Coll Cardiol 66:1–11
doi: 10.1016/j.jacc.2015.04.058
Nagashima K, Okumura Y, Watanabe I, Nakai T, Ohkubo K, Kofune T et al (2011) Association between epicardial adipose tissue volumes on 3-dimensional reconstructed CT images and recurrence of atrial fibrillation after catheter ablation. Circ J 75:2559–2565
doi: 10.1253/circj.CJ-11-0554
Sacks HS, Fain JN (2007) Human epicardial adipose tissue: a review. Am Heart J 153:907–917
doi: 10.1016/j.ahj.2007.03.019
Wong CX, Ganesan AN, Selvanayagam JB (2017) Epicardial fat and atrial fibrillation: current evidence, potential mechanisms, clinical implications, and future directions. Eur Heart J 38:1294–1302
doi: 10.1093/eurheartj/ehx280
Mahajan R, Nelson A, Pathak RK, Nakai T, Ohkubo K, Kofune M et al (2018) Electroanatomical remodeling of the atria in obesity: impact of adjacent epicardial fat. JACC Clin Electrophysiol 4(12):1529–1540
doi: 10.1016/j.jacep.2018.08.014
Venteclef N, Guglielmi V, Balse E, Gaborit B, Cotillard A, Atassi F et al (2015) Human epicardial adipose tissue induces fibrosis of the atrial myocardium through the secretion of adipo-fibrokines. Eur Heart J 36:795–805
doi: 10.1093/eurheartj/eht099
Haemers P, Hamdi H, Guedj K, Suffee N, Farahmand P, Popovic N et al (2017) Atrial fibrillation is associated with the fibrotic remodelling of adipose tissue in the subepicardium of human and sheep atria. Eur Heart J 38:53–61
doi: 10.1093/eurheartj/ehv625
Nalliah CJ, Bell JR, Raaijmakers AJA, Waddell HM, Wells SP, Bernasoch GB et al (2020) Epicardial adipose tissue accumulation confers atrial conduction abnormality. J Am Coll Cardiol 76:1197–1211
doi: 10.1016/j.jacc.2020.07.017
Nagashima K, Okumura Y, Watanabe I, Nakai T, Ohkubo K, Kofune M et al (2012) Does location of epicardial adipose tissue correspond to endocardial high dominant frequency or complex fractionated atrial electrogram sites during atrial fibrillation? Circ Arrhythm Electrophysiol 5:676–683
doi: 10.1161/CIRCEP.112.971200
Nakahara S, Hori Y, Kobayashi S, Sakai Y, Taguchi I, Takayanagi K et al (2014) Epicardial adipose tissue- based defragmentation approach to persistent atrial fibrillation: its impact on complex fractionated electrograms and ablation outcome. Heart Rhythm 11:1343–1351
doi: 10.1016/j.hrthm.2014.04.040

Auteurs

Gustavo R Goldenberg (GR)

Cardiology Department, Israel and Sackler Faculty of Medicine, Rabin Medical Center, Tel Aviv University, Tel Aviv, Israel. Gustavogoldenberg0@gmail.com.
Electrophysiology and Pacing Unit, Department of Cardiology, Rabin Medical Center, Ze'ev Jabotinsky St 39, 4941492, Petah Tikva, Israel. Gustavogoldenberg0@gmail.com.

Ashraf Hamdan (A)

Cardiology Department, Israel and Sackler Faculty of Medicine, Rabin Medical Center, Tel Aviv University, Tel Aviv, Israel.

Alon Barsheshet (A)

Cardiology Department, Israel and Sackler Faculty of Medicine, Rabin Medical Center, Tel Aviv University, Tel Aviv, Israel.
Electrophysiology and Pacing Unit, Department of Cardiology, Rabin Medical Center, Ze'ev Jabotinsky St 39, 4941492, Petah Tikva, Israel.

Ian Neeland (I)

UT Southwestern Medical Center, Dallas, TX, USA.

Ehud Kadmon (E)

Cardiology Department, Israel and Sackler Faculty of Medicine, Rabin Medical Center, Tel Aviv University, Tel Aviv, Israel.
Electrophysiology and Pacing Unit, Department of Cardiology, Rabin Medical Center, Ze'ev Jabotinsky St 39, 4941492, Petah Tikva, Israel.

Hagai Yavin (H)

Cardiology Department, Israel and Sackler Faculty of Medicine, Rabin Medical Center, Tel Aviv University, Tel Aviv, Israel.

Alex Omelchenko (A)

Cardiology Department, Israel and Sackler Faculty of Medicine, Rabin Medical Center, Tel Aviv University, Tel Aviv, Israel.
Electrophysiology and Pacing Unit, Department of Cardiology, Rabin Medical Center, Ze'ev Jabotinsky St 39, 4941492, Petah Tikva, Israel.

Aharon Erez (A)

Cardiology Department, Israel and Sackler Faculty of Medicine, Rabin Medical Center, Tel Aviv University, Tel Aviv, Israel.
Electrophysiology and Pacing Unit, Department of Cardiology, Rabin Medical Center, Ze'ev Jabotinsky St 39, 4941492, Petah Tikva, Israel.

Ilan Marcuschamer (I)

Cardiology Department, Israel and Sackler Faculty of Medicine, Rabin Medical Center, Tel Aviv University, Tel Aviv, Israel.

Ran Kornowski (R)

Cardiology Department, Israel and Sackler Faculty of Medicine, Rabin Medical Center, Tel Aviv University, Tel Aviv, Israel.

Boris Strasberg (B)

Cardiology Department, Israel and Sackler Faculty of Medicine, Rabin Medical Center, Tel Aviv University, Tel Aviv, Israel.
Electrophysiology and Pacing Unit, Department of Cardiology, Rabin Medical Center, Ze'ev Jabotinsky St 39, 4941492, Petah Tikva, Israel.

Gregory Golovchiner (G)

Cardiology Department, Israel and Sackler Faculty of Medicine, Rabin Medical Center, Tel Aviv University, Tel Aviv, Israel.
Electrophysiology and Pacing Unit, Department of Cardiology, Rabin Medical Center, Ze'ev Jabotinsky St 39, 4941492, Petah Tikva, Israel.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH